Indeed, recombinant sTM, by replacing the vasculitis-induced depletion of membrane-bound local thrombomodulin, has been implicated in protection or reversal of vascular injury, disseminated intravascular coagulation (DIC) and in animal models of ARDS. This evidence concerns the gene THBD and Disseminated intravascular coagulation.